Gadolinium-based Contrast Agents for Cardiac MRI: Use of Linear and Macrocyclic Agents with Associated Safety Profile from 154 779 European Patients

Gadolinium-based contrast agents used in cardiac MRI have an acute adverse event rate of 0.38%; in Europe, macrocyclic contrast agents are primarily used and demonstrate a favorable safety profile ...